Drugs Made In America Acquisition Corp. Rights carries a market capitalization of 345.02M, placing it among publicly traded companies globally.
| Market Cap | 345.02M |
| Enterprise Value | N/A |
Drugs Made In America Acquisition Corp. Rights's stock has declined approximately -38.88889% over the past 52 weeks. The 50-day moving average sits at 0.11, while the 200-day moving average is 0.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | -38.88889% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.14 |
| Average Volume (20 Days) | N/A |